Antibiotic Cubicin Linked to Eosinophilic Pneumonia
Share The U.S. FDA announced that patients taking care of with Cubicin, an intravenous antibiotic, sprint an augmented threat of rising eosinophilic pneumonia, a uncommon and potentially life-threatening situation. Cubicin is the trade name for the generic medicine daptomycin. The medicine was first permitted in 2003 for taking care of severe skin infections and in [...] [...more]
